The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Regulatory News (ASHM)

Share Price Information for Ashmore (ASHM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 193.40
Bid: 193.10
Ask: 193.60
Change: 2.70 (1.42%)
Spread: 0.50 (0.259%)
Open: 190.10
High: 193.50
Low: 189.10
Prev. Close: 190.70
ASHM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

13 Jul 2018 07:00

RNS Number : 5175U
Ashmore Group PLC
13 July 2018
 

Ashmore Group plc13 July 2018

FOURTH QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces the following update to its assets under management ("AuM") in respect of the quarter ended 30 June 2018.

Assets under management

Theme

Actual31 March 2018

(US$ billion)

Estimated30 June 2018

(US$ billion)

Movement

(%)

External debt

15.3

14.5

-5%

Local currency

17.7

17.0

-4%

Corporate debt

9.4

9.8

+4%

Blended debt

20.7

19.7

-5%

Equities

4.3

4.2

-2%

Alternatives

1.5

1.5

-

Multi-asset

1.2

1.0

-17%

Overlay / liquidity

6.4

6.2

-3%

Total

76.5

73.9

-3%

 

Assets under management decreased by US$2.6 billion during the period, comprising net inflows of US$2.6 billion offset by negative investment performance of US$5.2 billion.

Net inflows were delivered in the local currency, corporate debt, blended debt and equities themes, with a broad range of institutional clients adding to mandates, as well as new accounts and continued retail demand through the intermediary channels. Capital was returned in the alternatives theme, and there were small net outflows in the external debt, overlay and multi-asset themes.

Investment performance was negative across all themes except alternatives, particularly reflecting foreign exchange weakness in the local currency and blended debt themes. As normal in a period of market volatility, Ashmore's investment committees have actively added risk where assets have been oversold in order to capture value and to sustain long-term outperformance. Ashmore's performance against benchmarks remains strong over one, three and five years.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Client activity levels continued to be broad-based through the quarter ahead of the typical seasonal slowdown. Asset prices weakened over the period, particularly in local currency markets, as returns were impacted by the combination of a stronger US dollar and weaker euro, risk aversion to developed world political uncertainty, and concerns about trade protectionism.

"This has left Emerging Markets valuations at levels last seen immediately after the US election in 2016, following which markets delivered a sustained rally. While there is a small number of emerging countries that face challenges, most Emerging Markets economies are in even better health today. Therefore the recent sell off has created significant value opportunities on which an active manager such as Ashmore can capitalise."

 

Notes

The investment performance figure of US$5.2 billion includes the effect of translating non-US dollar share classes or funds into US dollars for reporting purposes. Over the quarter, this resulted in a negative contribution to reported investment performance of US$0.6 billion.

For the translation of US dollar-denominated balance sheet items, the GBP:USD exchange rate was 1.3200 at 30 June 2018 (30 June 2017: 1.2946; 31 December 2017: 1.3513). For the translation of US dollar management fees, the average GBP:USD exchange rate for the financial year was 1.3464 (FY2016/17: 1.2766).

Ashmore will announce its financial results in respect of the year ended 30 June 2018 on 7 September 2018.

Ashmore's Legal Entity Identifier (LEI) is 549300U3L59WB4YI2X12.

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI ConsultingAndrew Walton +44 (0)20 3727 1514Laura Ewart +44 (0)20 3727 1160

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFERDIIFLIT
Date   Source Headline
25th Feb 20147:00 amRNSHalf Yearly Report
24th Feb 20143:14 pmRNSHolding(s) in Company
14th Jan 20147:00 amRNSQ2 AuM Statement
6th Jan 20148:36 amRNSDirector/PDMR Shareholding
26th Nov 20137:00 amRNSDirectorate Change
30th Oct 20132:51 pmRNSResult of AGM
29th Oct 20135:00 pmRNSAnnual Information Update
21st Oct 201312:03 pmRNSDirector/PDMR Shareholding
10th Oct 20137:00 amRNSInterim Management Statement
30th Sep 20135:08 pmRNSNotice of AGM
18th Sep 20134:40 pmRNSDirector/PDMR Shareholding
18th Sep 20134:36 pmRNSDirector/PDMR Shareholding
10th Sep 20137:00 amRNSFinal Results
2nd Aug 20134:28 pmRNSHolding(s) in Company
11th Jul 20137:00 amRNSQ4 AuM Statement
9th Jul 20135:43 pmRNSHolding(s) in Company
3rd Jul 20135:03 pmRNSDirector/PDMR Shareholding
24th Jun 20136:28 pmRNSHolding(s) in Company
21st Jun 20133:33 pmRNSHolding(s) in Company
17th Jun 20133:25 pmRNSHolding(s) in Company
13th Jun 20134:05 pmRNSHolding(s) in Company
7th Jun 201311:20 amRNSHolding(s) in Company
24th Apr 20137:00 amRNSCapital Markets Day
11th Apr 20137:00 amRNSInterim Management Statement
25th Mar 20134:30 pmRNSDirector/PDMR Shareholding
21st Mar 201311:36 amRNSHolding(s) in Company
22nd Feb 20134:30 pmRNSDirector/PDMR Shareholding
21st Feb 20137:00 amRNSHalf Yearly Report
19th Feb 20132:06 pmRNSAppointment of Directors
4th Dec 20125:30 pmRNSDirector/PDMR Shareholding
31st Oct 20124:38 pmRNSResult of AGM
26th Oct 20128:48 amRNSAnnual Information Update
11th Oct 20127:00 amRNSInterim Management Statement
1st Oct 20124:24 pmRNSNotice of AGM
21st Sep 20124:20 pmRNSDirector/PDMR Shareholding
11th Sep 20127:00 amRNSFinal Results
12th Jul 20127:00 amRNSTrading Statement
12th Apr 20127:00 amRNSInterim Management Statement
30th Mar 20126:01 pmRNSHolding(s) in Company
30th Mar 20126:00 pmRNSDirector/PDMR Shareholding
27th Feb 20125:10 pmRNSHolding(s) in Company
23rd Feb 20127:00 amRNSHalf Yearly Report
16th Feb 20125:58 pmRNSHolding(s) in Company
10th Feb 20127:00 amRNSDirectorate Change
12th Jan 20127:00 amRNSTrading Statement
22nd Nov 20119:14 amRNSDirector/PDMR Shareholding
8th Nov 20117:00 amRNSTotal Voting Rights
27th Oct 20115:30 pmRNSResult of AGM
26th Oct 20113:39 pmRNSAnnual Information Update
13th Oct 20117:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.